CompletedNot Applicable

Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas

United States72 participantsStarted 2023-03-29

Plain-language summary

The main objective of this study is to determine how physicians make decisions regarding surveillance of Intraductal Papillary Mucinous Neoplasm's (IPMN) of the pancreas.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Membership in either the PACYFIC or PRECEDE consortiums * Physician with expertise in the management of IPMN * Able and willing to complete survey Exclusion Criteria: * Not a member of either the PACYFIC or PRECEDE consortiums * Not a physician with expertise in the management of IPMN

What they're measuring

Number of Decisions to Stop Surveillance Imaging

Timeframe: Day 1

Number of Decisions to Continue Surveillance Imaging

Timeframe: Day 1

Trial details

NCT IDNCT06311032

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-06-28

View on ClinicalTrials.gov More Surgery Risk Assessment trials